Ascletis Pharma Inc. (HKG:1672)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.25
+0.43 (4.33%)
Aug 20, 2026, 4:09 PM HKT

Ascletis Pharma Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,82711,2412,9041,5225,1533,575
Market Cap Growth
-27.60%287.10%90.74%-70.46%44.13%13.38%
Enterprise Value
8,7149,272665-1,1972,236435
Last Close Price
10.2511.393.011.464.743.29

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
70.40107.41107.41107.41107.41107.41
PS Ratio
4797.704980.842126.8124.4284.2737.89
PB Ratio
5.035.221.390.591.801.07
P/TBV Ratio
5.065.251.400.601.811.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-4108.47486.91-36.574.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.000.00
Net Debt / Equity Ratio
-0.98-0.98-0.99-0.98-0.98-0.92
Net Debt / EBITDA Ratio
4.024.024.987.787.6912.21
Net Debt / FCF Ratio
4.544.545.669.9811.8416.46
Asset Turnover
0.000.000.000.020.020.03
Inventory Turnover
0.480.480.112.302.050.66
Quick Ratio
15.0015.0012.8216.5023.2428.26
Current Ratio
15.0515.0512.8816.5823.5228.93
Return on Equity (ROE)
-18.45%-18.45%-13.97%-5.93%-11.95%-6.97%
Return on Assets (ROA)
-14.45%-14.45%-10.96%-7.50%-7.94%-4.88%
Return on Capital Employed (ROCE)
-25.00%-25.00%-20.50%-13.10%-13.70%-8.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.70%-3.56%-11.03%-10.47%-6.91%-6.83%
FCF Yield
-4.30%-4.14%-12.60%-16.64%-4.60%-5.21%
Buyback Yield / Dilution
2.90%2.90%6.75%1.19%0.96%-5.53%